|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/519 | (2013.01) |
| (11) | Patento numeris | 3533449 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17864975.2 |
| Europos patento paraiškos padavimo data | 2017-10-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-09-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-07-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2017/037186 |
| Data | 2017-10-13 |
| (87) | Numeris | WO 2018/079310 |
| Data | 2018-05-03 |
| (30) | Numeris | Data | Šalis |
| 2016213072 | 2016-10-31 | JP |
| (72) |
MIYADERA, Kazutaka , JP
AOYAGI, Yoshimi , JP
HASAKO, Shinichi , JP
|
| (73) |
Taiho Pharmaceutical Co., Ltd. ,
1-27 Kandanishiki-cho, Chiyoda-ku
Tokyo 101-8444,
JP
|
| (54) | SELECTIVE INHIBITOR OF EXON 20 INSERTION MUTANT EGFR |
| SELECTIVE INHIBITOR OF EXON 20 INSERTION MUTANT EGFR |